Security key
218352102
CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT)
CUSIP: 218352102
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 81,489,147
- Total 13F value
- $1,813,024,077
- Share change
- -5,875,634
- Put/Call ratio
- 71%
- SEC-reported price per share
- $22.25
- Number of holders
- 224
- Value change
- -$128,901,748
- Number of buys
- 89
- Number of sells
- 128
- Shares outstanding
- 106,815,676
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
224
Top holders
10
CORT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2023
Previous quarter: Q1 2023
CORCEPT THERAPEUTICS INC SEC filings
CORCEPT THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 218352102
Recent filing periods:
Ownership snapshot
Top reported holders of CORT - CORCEPT THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2023
13F
Lead comparable stake: 15%
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. leads the comparable SEC ownership view at 15%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock Finance, Inc.
15%
VANGUARD GROUP INC
9.8%
INGALLS & SNYDER LLC
7.8%
RENAISSANCE TECHNOLOGIES LLC
6.4%
Parallel Advisors, LLC
3.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
15%
|
$349,350,134
16,128,815 shares
|
— | 31 Mar 2023 |
| VANGUARD GROUP INC |
13F
Company
|
9.8%
|
$226,016,556
10,434,744 shares
|
— | 31 Mar 2023 |
| INGALLS & SNYDER LLC |
13F
Company
|
7.8%
|
$181,295,000
8,370,017 shares
|
— | 31 Mar 2023 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
6.4%
|
$147,030,000
6,788,069 shares
|
— | 31 Mar 2023 |
| Parallel Advisors, LLC |
13F
Company
|
3.5%
|
$80,674,251
3,724,573 shares
|
— | 31 Mar 2023 |
| Novo Holdings A/S |
13F
Company
|
3.2%
|
$73,162,455
3,377,768 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
224
Shares
81,489,147
Rows available
224
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
231
Q2 2023 holders
224
Holder diff
-7
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend